FOXO4 is a peptide studied for its potential senolytic properties and effects on cellular aging and senescent cell clearance.
FOXO4-DRI is a modified peptide that disrupts the interaction between FOXO4 and p53 proteins in senescent cells. This peptide is designed to selectively induce apoptosis in senescent cells. Researchers study FOXO4 for its potential senolytic effects and impact on aging processes in laboratory settings.
Research on FOXO4 examines its senolytic properties and effects on cellular aging. Studies focus on its ability to disrupt FOXO4-p53 interaction, induce selective apoptosis in senescent cells, and impact tissue rejuvenation. Researchers investigate its mechanisms involving senescent cell clearance, p53 activation in aged cells, and potential anti-aging effects in experimental models.
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.

Explore similar peptides and compounds that researchers often study together